This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Hisamitsu Pharmaceutical Company, Inc., Teijin Limited. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1977
Title: Kazuki Furuya: Innovator in Pharmaceutical Composition
Introduction
Kazuki Furuya is a notable inventor based in Tosu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address specific medical needs. His innovative approach has led to the creation of a unique patent that showcases his expertise.
Latest Patents
Kazuki Furuya holds a patent for a "Stripe composition and method of reducing smell associated therewith." This stupe composition comprises a stupe base and an antiphlogistic and analgesic medicine. The medicine contains an interacted compound selected from the group consisting of an interacted compound of menthol and a cyclodextrin, as well as an interacted compound of methyl salicylate and a cyclodextrin. The composition is prepared by uniformly mixing a stupe base and the interacted compound. This patent highlights his innovative approach to reducing unpleasant odors associated with pharmaceutical products.
Career Highlights
Throughout his career, Kazuki Furuya has worked with prominent companies in the pharmaceutical industry. He has been associated with Hisamitsu Pharmaceutical Company, Inc. and Teijin Limited. His experience in these organizations has contributed to his development as an inventor and has provided him with valuable insights into the industry.
Collaborations
Kazuki Furuya has collaborated with notable coworkers, including Kanji Noda and Satoru Miyata. These collaborations have likely enriched his work and contributed to the success of his inventions.
Conclusion
Kazuki Furuya is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact. His innovative patent demonstrates his commitment to improving medical products and addressing specific needs in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile